September 10, 2012 — In a recent clinical trial, the Solitaire Flow Restoration Device dramatically outperformed the ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
September 7, 2012 — St. Jude Medical Inc. announced results of the FAME II trial demonstrating that patients with fracti ...
September 6, 2012 — Drug-eluting stents (DES) are used less often in women treated with percutaneous coronary ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
September 6, 2012 — Daiichi Sankyo Co. Ltd. and Eli Lilly and Co. announced data from the TRILOGY ACS study, a phase III ...
Sept. 4, 2012 — Medtronic has reached two clinical program milestones for its CoreValve transcatheter aortic valve ...
September 4, 2012 — Philips Heathcare announced that mVisum Inc.’s STEMI Alert smartphone app is now available to work ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Sept. 3, 2012 — Due to newly released evidence linking the aftermath of Japan’s 2011 earthquake with an increase in the ...
August 30, 2012 — According to Millennium Research Group (MRG), an authority on the medical technology market, as ...
Vascular closure devices that use an active method to immediately seal the femoral access site can enable faster patient ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
The implementation of dedicated access site surveillance and educational programs, in tandem with pre-existent ...
Recently, concerns have been raised that transradial (TR) cardiac catheterization significantly increases radiation ...
A major issue with clopidogrel is that one-third of patients are nonresponders because they lack the enzymes to ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
The standard-of-care for dual antiplatelet therapy (DAPT) for more than a decade has been clopidogrel (Plavix) plus ...
August 23, 2012 — Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, finds that ...
August 23, 2012 – Philips Healthcare and Corindus Vascular Robotics announced a distribution agreement for Corindus’ ...